Human Menopausal Gonadotrophins

A natural hormone present in the urine of menopausal women which has the activity of follicle stimulating hormone (FSH) and luteinizing hormone (LH). When these hormones, FSH and LH, are in a 1:1 ratio, the product is known as menotropin.
Administration by subcutaneous or intramuscular injection.
Indicated to stimulate ovulation in assisted reproduction techniques.

Since the last update we have not found published data on its excretion in breastmilk.

Its high molecular weight makes it very unlikely it will transfer into milk in significant quantities.

Due to its protein nature it is inactivated in the gastrointestinal tract, not being absorbed, so its oral bioavailability is practically nil, except in premature babies and the immediate neonatal period when there may be greater intestinal permeability.

No adverse effects have been recorded in infants.

In infertility treatments, the possible theoretical anovulatory effect of frequent on demand breastfeeding must be taken into account.

• Choriogonadotropin Alfa (Low Risk probable)
• Follitropin (Low Risk probable)
• Human Chorionic Gonadotrophin (Low Risk probable)
• Lutropin (Low Risk probable)

Alternatives

We do not have alternatives for Human Menopausal Gonadotrophins.